Filter
471
Filtered Results: 471
Text search:
International
Pharmaceutical
Federation
Featured
Recommendations
47
New Publications
111
Language
Document type
No document type
241
Studies & Reports
95
Guidelines
67
Manuals
25
Strategic & Response Plan
20
Training Material
13
Fact sheets
5
Situation Updates
2
Resource Platforms
2
Brochures
1
Countries / Regions
Global
27
India
21
Western and Central Europe
18
Nigeria
16
Ukraine
13
Kenya
10
South Africa
9
Eastern Europe
8
Nepal
6
Syria
6
Africa
6
Ethiopia
6
Eastern Europe and Central Asia
5
Sierra Leone
4
Latin America and the Carribbean
4
Germany
4
Uganda
4
Russia
4
Lesotho
3
Cameroon
3
Asia
3
Brazil
3
Liberia
3
Myanmar / Burma
3
North Macedonia
2
Rwanda
2
Senegal
2
Kyrgyzstan
2
Zimbabwe
2
Philippines
2
Venezuela
2
Tanzania
2
Congo, Democratic Republic of
2
Bangladesh
2
Moldova
2
Namibia
2
South Sudan
2
Tajikistan
1
Serbia
1
Ghana
1
Kazakhstan
1
Albania
1
Laos
1
Niger
1
Uzbekistan
1
Malawi
1
Bulgaria
1
Guinea
1
Armenia
1
Haiti
1
Jordan
1
South–East Asia Region
1
Turkmenistan
1
Portugal
1
Yemen
1
Georgia
1
Mali
1
Chad
1
Botswana
1
Zambia
1
Indonesia
1
Iraq
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
124
Clinical Guidelines
43
Public Health
27
Key Resources
23
Women & Child Health
16
Capacity Building
10
Pharmacy & Technologies
9
Toolboxes
Mental Health
37
AMR
37
TB
36
COVID-19
36
HIV
34
Pharmacy
34
NCDs
21
Rapid Response
18
Conflict
18
Caregiver
11
Global Health Education
10
Planetary Health
9
Refugee
6
Ebola
6
NTDs
6
Health Financing Toolbox
6
Specific Hazards
5
Natural Hazards
4
Disability
3
Polio
3
Zika
1
In India, in response to the above and guided by our counterparts in the government of India, the UN agencies have developed the Novel Coronavirus Disease Joint Health Response Plan by UN Agencies and Partners, led by WHO-India, in close collaboration with the Ministry of Health and Family Welfare, ...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
This document offers public health guidance for the prevention and control of COVID-19 in reception centres, and other temporary accommodation facilities, in the context of the mass influx of Ukrainian people into the European Union (EU), the European Economic Area (EEA) and the Republic of Moldova.
The climate crisis has many consequences – among them widespread health impacts that will lead to immense societal, ecological, and economic harm.
Over the past two decades multiple large-scale reviews on climate change and health have made clear the need for a multi-sectoral approach to target t...
Getting on track to end AIDS as a public health threat by 2030. This new Road Map charts a way forward for country-level actions to achieve an ambitious set of HIV prevention targets by 2025. Those targets emerged from the 2021 Political Declaration on HIV and AIDS, which the United Nations General ...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Access to health workers who are fit for purpose, motivated and protected is a fundamental force of health service delivery and the achievement of universal health coverage and the health and health-related Sustainable Development Goals. Data and knowledge of the distribution, skill mix and future d...
This report includes six case studies from 12 individuals with lived experience of diverse health conditions. These case studies explore the topics of power dynamics and power reorientation towards individuals with lived experience; informed decision-making and health literacy; community engagement ...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
Since the discovery of insulin nearly 100 years ago, advances in diabetes treatments and therapies have transformed the lives of people
with diabetes (PwD), notably reducing the daily burden of its management.
Newer technologies, including those driven by artificial intelligence, have the potentia...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
Building laboratory testing capacity
